Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 243

Results For "IP"

11099 News Found

Max Institute partners with Intuitive Surgical to expand robotic-assisted surgery in India
News | January 21, 2026

Max Institute partners with Intuitive Surgical to expand robotic-assisted surgery in India

The collaboration will focus on enhancing surgeon capabilities, developing structured training pathways, and promoting the adoption of robotic-assisted surgery in both routine and complex procedures


AstraZeneca to withdraw Nasdaq listings ahead of NYSE direct listing
News | January 21, 2026

AstraZeneca to withdraw Nasdaq listings ahead of NYSE direct listing

The move follows AstraZeneca’s previously announced plan to complete a direct listing of its Ordinary Shares and debt securities on the New York Stock Exchange


Sigachi Industries achieves key R&D milestone in Cystic Fibrosis APIs
R&D | January 21, 2026

Sigachi Industries achieves key R&D milestone in Cystic Fibrosis APIs

The development marks an important step in Sigachi's strategic focus on expanding its presence in complex, high-value specialty APIs, aligned with global demand for advanced therapies in rare and chronic disease segments


Tatva Chintan Pharma Chem posts consolidated Q3 FY26 at Rs. 15.16 Cr
News | January 21, 2026

Tatva Chintan Pharma Chem posts consolidated Q3 FY26 at Rs. 15.16 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 133.06 crore during the period ended December 31, 2025


Alto Neuroscience bags new US patent for depression drug ALTO-207
News | January 20, 2026

Alto Neuroscience bags new US patent for depression drug ALTO-207

ALTO-207 combines pramipexole, a dopamine D3-preferring D3/D2 agonist approved for Parkinson’s disease


Symeres rehires Jurgen Berendsen as CFO amid strategic growth push
People | January 20, 2026

Symeres rehires Jurgen Berendsen as CFO amid strategic growth push

Berendsen brings over 15 years of financial leadership experience spanning professional services and international trade


Kindeva appoints David Stevens as new CEO
People | January 20, 2026

Kindeva appoints David Stevens as new CEO

Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors


Avalon clinches majority investment to expand future of diagnostic intelligence
News | January 20, 2026

Avalon clinches majority investment to expand future of diagnostic intelligence

The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities


IDT and Ansa Biotechnologies join forces to push limits of DNA synthesis
Biotech | January 20, 2026

IDT and Ansa Biotechnologies join forces to push limits of DNA synthesis

The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability


China nod to two Sanofi drugs for rare and complex conditions
Drug Approval | January 20, 2026

China nod to two Sanofi drugs for rare and complex conditions

Myqorzo, a selective small-molecule cardiac myosin inhibitor, is designed to improve functional capacity and relieve symptoms in oHCM